Source: FDA, National Drug Code (US) Revision Year: 2020
EVENITY is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
The anabolic effect of EVENITY wanes after 12 monthly doses of therapy. Therefore, the duration of EVENITY use should be limited to 12 monthly doses. If osteoporosis therapy remains warranted, continued therapy with an anti-resorptive agent should be considered [see Dosage and Administration (2.2) and Clinical Studies (14.1)].
Step 1: Prior to Administration:
Step 2: Select the Injection Site and Prepare the Syringe:
Prepare and clean two injection sites, one for each of the two injections. See Figure B.
The recommended subcutaneous injection sites include:
Clean the injection sites with alcohol wipes. Let the skin dry.
Choose the first syringe. Pull the gray needle cap straight off and away from your body when you are ready to inject. See Figure C.
Step 3: Inject EVENITY
Insert needle and inject all the liquid subcutaneously. Do not administer into muscle or blood vessel. See Figure D.
When done, gently lift the syringe off of the skin.
Step 4: Syringe and Needle Cap Disposal
Immediately dispose of the syringe and needle cap in the nearest sharps container.
Important: Repeat all steps with the second syringe to inject the full dose.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.